Tech & Gadgets

Chickens without eggs? De-extinction company creates artificial egg.

28 sec read2 views0 listens

Biotech startup Colossal has developed an artificial eggshell that allows avian embryos to develop normally outside of a traditional shell. This breakthrough provides a critical platform for de-extinction efforts and offers researchers a transparent, accessible environment for precise genetic manipulation and observation of vertebrate development. Tech professionals should monitor how this scalable ex-ovo technology accelerates progress in synthetic biology and the restoration of endangered bird species.

Read the full article at Ars Technica

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

Collaborative Drug Discovery Inks Deal with Eli Lilly to Accelerate Biotech Innovation

Collaborative Drug Discovery is integrating Eli Lilly’s TuneLab predictive models directly into the CDD Vault platform to provide biotech firms with proprietary ADMET research data. This partnership allows developers and data scientists to deploy eli...

Ali Nemati

Cybersecurity1 day ago27 sec read

Certes Research Warns Legacy Systems Are Biggest Barrier to Quantum Security Readiness

Certes research reveals that legacy systems are the primary barrier to quantum security readiness for most organizations, with 78% of surveyed IT and security leaders citing outdated infrastructure as their biggest risk. This highlights a critical ga...

Ali Nemati

Real Estate & Home1 day ago37 sec read

Study: Bipartisan Social Security plan to borrow and invest unlikely to pay off

A high-profile bipartisan proposal to borrow $1.5 trillion to invest in stocks as a solution to Social Security's projected 2034 shortfall is unlikely to succeed, even under optimistic market conditions, according to new research. For proptech and ho...

Ali Nemati

Tech & Gadgets1 day ago32 sec read

Two AI-based science assistants succeed with drug-retargeting tasks

Google and FutureHouse have introduced two agentic AI systems—Co-Scientist and a separate nonprofit project—designed to assist scientists with tasks like drug retargeting by processing vast amounts of biological data. This matters to developers and r...

Ali Nemati

Biotech & Pharma1 day ago26 sec read

Google DeepMind and Edison Are Building the AI Scientist

Google DeepMind and Edison Scientific are developing AI platforms to automate scientific research, aiming to accelerate drug discovery by integrating hypothesis generation, experimental design, and data interpretation. This development is crucial for...

Ali Nemati

Chickens without eggs? De-extinction company creates artificial egg.

Related Articles

Collaborative Drug Discovery Inks Deal with Eli Lilly to Accelerate Biotech Innovation

Certes Research Warns Legacy Systems Are Biggest Barrier to Quantum Security Readiness

Study: Bipartisan Social Security plan to borrow and invest unlikely to pay off

Two AI-based science assistants succeed with drug-retargeting tasks

Google DeepMind and Edison Are Building the AI Scientist